G
GOSS
Gossamer Bio
9.28
-0.03-0.32%After Hours: 9.29 +0.01 +0.11%19:30 10/12 EDT
OPEN/PREV CLOSE9.54/9.31
TODAY RANGE8.99-9.54
VOL155.21K
MARKET CAP56.76M
52 WEEK RANGE8.99-309.60
AVG VOL (3M)377.07K
% TURNOVER2.39%
TURNOVER--
P/E (TTM)-0.2060
% RANGE4.30%
EPS(TTM)-45.0427
P/E(FORWARD)-0.5615
P/B-0.6031
BVPS-15.3879
DIVIDEND--
P/S0.5592
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP55.95M
SHARES OUTSTANDING6.12M
NEXT EARNINGS11/03-11/09
FREE FLOAT6.03M
LOT SIZE1
EX-DATE09/11/2026
News
Press Releases
Financial Reports
Profile
TipRanks·09/28 21:15
Gossamer Bio Regains Nasdaq Listing Bid Price Compliance
Benzinga·09/25 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
TipRanks·09/24 11:16
Guggenheim Sticks to Their Hold Rating for Gossamer Bio (GOSS)
TipRanks·09/23 23:55
Closing Bell Movers: Stitch Fix down 18% after results and guidance
TipRanks·09/23 20:31
Gossamer Bio Files First NDA for Seralutinib PAH Drug
Dow Jones·09/21 10:38
Gossamer Bio Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·09/21 10:38
Gossamer Bio Price Target Raised to $90.00/Share From $2.00 by HC Wainwright & Co.
Benzinga·09/21 10:27
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90
TipRanks·09/21 10:15
Gossamer Bio target adjusted to $90 for split at H.C. Wainwright
Benzinga·09/18 21:06
12 Health Care Stocks Moving In Friday's After-Market Session
TipRanks·09/16 20:32
Gossamer Bio Adds Veteran Investor to Board of Directors
Dow Jones·09/16 20:01
*Gossamer Bio Appoints Greg Ciongoli to Bd of Directors
TipRanks·09/11 12:59
Gossamer Bio Executes Reverse Stock Split and Share Reduction
Same Industry
Name/Symbol
Change%
Price